The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Belopasova A.V.

Research Center of Neurology

Dobrynina L.A.

Research Center of Neurology

Kalashnikova L.A.

Research Center of Neurology

Chechetkin A.O.

Research Center of Neurology

Karshieva A.R.

Research Center of Neurology

Abugov S.A.

Petrovsky National Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Mardanyan G.V.

Petrovsky National Research Center of Surgery

Puretsky M.V.

Petrovsky National Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Shteklein A.B.

Peoples' Friendship University of Russia

Pulmonary arteriovenous shunt — a rare cause of recurrent stroke due to paradoxical embolism

Authors:

Belopasova A.V., Dobrynina L.A., Kalashnikova L.A., Chechetkin A.O., Karshieva A.R., Abugov S.A., Mardanyan G.V., Puretsky M.V., Shteklein A.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9): 107‑113

DOI: 10.17116/jnevro2020120091107

Read: 11514 times

Download PDF (RU)
Contact the author
Table of contents

PULMONARY ARTERIOVENOUS SHUNT — A RARE CAUSE OF RECURRENT STROKE DUE TO PARADOXICAL EMBOLISM
PULMONARY ARTERIOVENOUS SHUNT — A RARE CAUSE OF RECURRENT STROKE DUE TO PARADOXICAL EMBOLISM

To cite this article:

Belopasova AV, Dobrynina LA, Kalashnikova LA, et al. . Pulmonary arteriovenous shunt — a rare cause of recurrent stroke due to paradoxical embolism. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(9):107‑113. (In Russ.)
https://doi.org/10.17116/jnevro2020120091107

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Paradoxical embolism is one of the mechanisms of ischemic stroke in patients younger than 45 years of age, due to opening between the right and left chambers of the heart through a patent foramen ovale, an atrial or ventricular septal defect, pulmonary arteriovenous malformations (PAVMs), etc. The PAVMs are structurally abnormal vessels that provide direct capillary-free communication between the pulmonary and systemic circulations, and hence an anatomic “right-to-left” shunt. Most pulmonary malformations are congenital and associated with hereditary hemorrhagic telangiectasia (Rendu—Osler—Weber disease). This publication highlights the issues of pathogenesis, clinical presentation, diagnosis and treatment of this pathology, and also describes a clinical case in which multiple PAVMs caused repeated ischemic strokes.

Keywords:

young stroke
pulmonary arteriovenous malformations
pulmonary shunt
pulmonary fistula
paradoxical embolism
hereditary hemorrhagic telangiectasia
Rendu—Osler—Weber disease

Authors:

Belopasova A.V.

Research Center of Neurology

Dobrynina L.A.

Research Center of Neurology

Kalashnikova L.A.

Research Center of Neurology

Chechetkin A.O.

Research Center of Neurology

Karshieva A.R.

Research Center of Neurology

Abugov S.A.

Petrovsky National Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Mardanyan G.V.

Petrovsky National Research Center of Surgery

Puretsky M.V.

Petrovsky National Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Shteklein A.B.

Peoples' Friendship University of Russia

Received:

09.04.2020

Accepted:

20.04.2020

Close metadata

References:

  1. Dobrynina LA, Kalashnikova LA, Pavlova LN. Ischemic stroke in young adults. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(3):4-8. (In Russ.).
  2. Fu Q, Guo X, Mo D, Chen B. Young Paradoxical Stroke Treated Successfully with Mechanical Thrombectomy Using Solitaire and Transcatheter Closure of Patent Foramen Oval. Int Heart J. 2017;58(5):812-815.  https://doi.org/10.1536/ihj.16-461
  3. Homma S, Messé S, Rundek T, Sun YP, Franke J, Davidson K, Sievert H, Sacco R, Tullio M. Patent foramen ovale. Nature Reviews Disease Primers. 2016;2(1):15.  https://doi.org/10.1038/nrdp.2015.86
  4. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.  https://doi.org/10.1161/01.str.24.1.35
  5. Homma S, Sacco R. Patent Foramen Ovale and Stroke. Circulation. 2005;112(7):1063-1072. https://doi.org/10.1161/circulationaha.104.524371
  6. Cottin V, Chinet T, Lavolé A, Corre R, Marchan E, Reynaud-Gaubert M, Plauchu H, Cordier JF. and the Groupe d,Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Medicine (Baltimore). 2007;86(1):1-17.  https://doi.org/10.1097/md.0b013e31802f8da1
  7. Sloan RD, Cooley RN. Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med. 1953;70(2):183. PMID 13065567 
  8. Nakayama M, Nawa T, Chonan T, Endo K, Morikawa S, Bando M, Wada Y, Shioya T, Sugiyama Y, Fukai S. Prevalence of Pulmonary Arteriovenous Malformations as Estimated by Low-Dose Thoracic CT Screening. Internal Medicine. 2012;51(13):1677-1681. https://doi.org/10.2169/internalmedicine.51.7305
  9. Biryukov YuV, Khuan Yuan’fen, Pomelova LA. Current diagnosis and treatment of arteriovenous pulmonary malformations. Akademicheskii zhurnal Zapadnoi Sibiri. 2013;9(3):29-30. (In Russ.).
  10. Kraemer N, Krombach GA. Images in clinical medicine: Pulmonary arteriovenous fistula. Engl J Med. 2009;360:1769. https://doi.org/10.1056/NEJMicm0803889
  11. Kerut E. Intrapulmonary Shunts and Their Clinical Implications for the Echocardiographer. Echocardiography. 2015;32:S189-S189. https://doi.org/10.1111/echo.12889
  12. Kemezh YuV. Multispiral computed tomography scan in diagnosis of lungs arteriovenous malformations. Rossiiskii elektronnyi zhurnal luchevoi diagnostiki. 2013;3(11):27-32. (In Russ.).
  13. Ternovogo SK, Shekhtera AI. Radiation diagnostics of chest organ diseases. 2010;80. 
  14. Lacombe P, Lacout A, Marcy P-Y, Binsse S, Sellier J, Bensalah M, Chinet T, Bourgault-Villada I, Fagnou C, Ozanne A, Chagnon S, Hajjam M. Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. Diagn Interv Imaging. 2013;94(9):835-848.  https://doi.org/10.1016/j.diii.2013.03.014
  15. Contegiacomo A, del Ciello A, Rella R, Attempati N, Coppolo D, Larici AR, Di Stasi C, Marano G, Manfredi R. Pulmonary arteriovenous malformations: what the interventional radiologist needs to know. Radiol Med. 2019;124(10):973-988.  https://doi.org/10.1007/s11547-019-01051-7
  16. Elmali M, Akan H, Findik S, Kale M, Celenk C. Hereditary Hemorrhagic Telangiectasia Associated With Pulmonary Arteriovenous Malformations Presenting as Hemothorax. J Thorac Imaging. 2008;23(4):295-297.  https://doi.org/10.1097/rti.0b013e3181820867
  17. McDonald J, Pyeritz R. Hereditary Hemorrhagic Telangiectasia. Ncbi.nlm.nih.gov.  https://www.ncbi.nlm.nih.gov/books/NBK1351/. Published 2020. Accessed March 26, 2020.
  18. de Gussem E, Lausman A, Beder A, Edwards C, Blanker M, Terbrugge K, Mager J, Faughnan M. Outcomes of Pregnancy in Women With Hereditary Hemorrhagic Telangiectasia. Obstetrics & Gynecology. 2014;123(3):514-520.  https://doi.org/10.1097/aog.0000000000000120
  19. Shcheglov DV, Nosenko NN, Konotopchik SV, Chebanyuk SV. Hereditary hemorrhagic telangiectasia, or Osler-Rondu-Veber disease. Endovaskulyarnaya neirorentgenokhirurgiya. 2016;1(15):73-86. (In Russ.).
  20. Saboo S, Chamarthy M, Bhalla S, Park H, Sutphin P, Kay F, Battaile J, Kalva S. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325-337.  https://doi.org/10.21037/cdt.2018.06.01
  21. Holzer R, Cua C. Pulmonary Arteriovenous Malformations and Risk of Stroke. Cardiol Clin. 2016;34(2):241-246.  https://doi.org/10.1016/j.ccl.2016.01.001
  22. Ryan D, O’Connor T, Murphy M, Brady A. Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Clin Radiol. 2017;72(3):236-241.  https://doi.org/10.1016/j.crad.2016.12.002
  23. Handa T, Okano Y, Nakanishi N, Morisaki T, Morisaki H, Mishima M. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: A case report. Respir Investig. 2014;52(3):195-198.  https://doi.org/10.1016/j.resinv.2013.08.003
  24. Matsutani N, Dejima H, Takahashi Y, Uehara H, Iinuma H, Tanaka F, Kawamura M. Birt-Hogg-Dube syndrome accompanied by pulmonary arteriovenous malformation. J Thorac Dis. 2016;8(10):E1187-E1189. https://doi.org/10.21037/jtd.2016.09.68
  25. Shovlin C. Pulmonary Arteriovenous Malformations. Am J Respir Crit Care Med. 2014;190(11):1217-1228. https://doi.org/10.1164/rccm.201407-1254ci
  26. Gossage J, Mandel J. Pulmonary arteriovenous malformations: Clinical features and diagnostic evaluation in adults. Geraldine Finlay. 2019; Aug. 21  https://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-clinical-features-and-diagnostic-evaluation-in-adults
  27. Wong H, Chan R, Klatt R, Faughnan M. Idiopathic pulmonary arteriovenous malformations: clinical and imaging characteristics. European Respiratory Journal. 2010;38(2):368-375.  https://doi.org/10.1183/09031936.00075110
  28. Angriman F, Ferreyro B, Wainstein E, Serra M. Pulmonary Arteriovenous Malformations and Embolic Complications in Patients With Hereditary Hemorrhagic Telangiectasia. Archivos de Bronconeumología (English Edition). 2014;50(7):301-304.  https://doi.org/10.1016/j.arbr.2014.05.009
  29. Shin J, Park S, Ko G-Y, Yoon H-K, Gwon D-I, Kim J-H, Sung K-B. Embolotherapy for Pulmonary Arteriovenous Malformations in Patients without Hereditary Hemorrhagic Telangiectasia. Korean J Radiol. 2010;11(3):312.  https://doi.org/10.3348/kjr.2010.11.3.312
  30. Shovlin C, Jackson J, Bamford K, Jenkins I, Benjamin A, Ramadan H, Kulinskaya E. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008;63(3):259-266.  https://doi.org/10.1136/thx.2007.087452
  31. Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, Ma TY-Z. Pulmonary arteriovenous malformations: Cerebral ischemia and neurologic manifestations. Neurology. 2000;55(7):959-964.  https://doi.org/10.1212/wnl.55.7.959
  32. Chechetkin AO, Karshieva AR, Kravchenko MA, Belopasova AV, Kalashnikova LA, Dobrynina LA. Legochnyi arterio-venoznyi shunt kak prichina paradoksal’noi embolii: vozmozhnosti ul’trazvukovoi diagnostiki. Vestnik voenno-meditsinskoi akademii. 2019;3(67):162-164. (In Russ.). https://doi.org/10.32863/1682-7392-2019-3-67-162-164
  33. Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C, Kjeldsen A, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66-67. https://doi.org/10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p "> 3.0.co;2-p" target="_blank">https://doi.org/10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p
  34. Morphet J. Osler-Weber-Rendu syndrome. Can Med Assoc J. 2006;175(10):1243-1243. https://doi.org/10.1503/cmaj.1060182
  35. Faughnan M, Palda V, Garcia-Tsao G, Geisthoff U, McDonald J, Proctor D, Spears J, Brown, Buscarinr E, Chesnutt M, Cottin V, Ganguly A, Gossage J, Guttmacher A, Hyland R, Kennedy S, Korzenik J, Mager J, Ozanne A, Piccirillo J, Picus D, Plauchu H, Porteus M, Pyeritz R, Ross D, Sabba C, Swansos K, Terry P, Wallace M, Westermann C, White R, Young L, Zarrabeitia R. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2009;48(2):73-87.  https://doi.org/10.1136/jmg.2009.069013
  36. Nanda S, Bhatt S. Hereditary hemorrhagic telangiectasia: epistaxis and hemoptysis. Can Med Assoc J. 2009;180(8):838-838.  https://doi.org/10.1503/cmaj.081003
  37. Ando K, Mochizuki A, Kurimoto N, Yokote K, Nakajima Y, Osada H, Nakamura H. Coil Embolization for Pulmonary Arteriovenous Malformation as an Organ-sparing Therapy: Outcome of Long-term Follow-up. Annals of Thoracic and Cardiovascular Surgery. 2011;17(2):118-123.  https://doi.org/10.5761/atcs.oa.10.01536
  38. Babaker M, Breault S, Beigelman C, Lazor R, Aebischer N, Qanadli S. Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Swiss Med Wkly. 2015 Jul 28;145:w14151. https://doi.org/10.4414/smw.2015.14151
  39. Fetisov NI, Maskin SS. Arteriovenous anomalies of lung vessels: pathomorphology, diagnostics, surgical treatment. Vestnik khirurgii. 2017;176(3):102-107. (In Russ.). https://doi.org/10.24884/0042-4625-2017-176-3-102-107
  40. Bobrov EI. Pulmonary arteriovenous fistulas: diagnostics and endovascular treatment. Regional’noe krovoobrashchenie i mikrotsirkulyatsiya. 2003;2:11-16. (In Russ.).
  41. Pereira-da-Silva T, Martins J, de Sousa L, Fiarresga A, Pereira C, Ferreira R, Pinto F. Percutaneous occlusion of vascular malformations in pediatric and adult patients: 20-Year Experience of a Single Center. Catheterization and Cardiovascular Interventions. 2015;87(2):E62-E68.  https://doi.org/10.1002/ccd.26220
  42. Shibamoto Y. Triaxial System in Re-Embolization for Recanalization of Pulmonary Arteriovenous Malformations. Pol J Radiol. 2015;80:67-71.  https://doi.org/10.12659/pjr.892378
  43. Remy-Jardin M, Dumont P, Brillet P, Dupuis P, Duhamel A, Remy J. Pulmonary Arteriovenous Malformations Treated with Embolotherapy: Helical CT Evaluation of Long-term Effectiveness after 2–21-Year Follow-up. Radiology. 2006;239(2):576-585.  https://doi.org/10.1148/radiol.2391050333
  44. Shimohira M, Kawai T, Hashizume T, Ohta K, Nakagawa M, Ozawa Y, Sakurai K, Shibamoto Y. Reperfusion Rates of Pulmonary Arteriovenous Malformations after Coil Embolization: Evaluation with Time-Resolved MR Angiography or Pulmonary Angiography. Journal of Vascular and Interventional Radiology. 2015;26(6):856-864.e1.  https://doi.org/10.1016/j.jvir.2015.02.016
  45. Dittus C. Bleeding and clotting in hereditary hemorrhagic telangiectasia. World J Clin Cases. 2015;3(4):330.  https://doi.org/10.12998/wjcc.v3.i4.330
  46. Shovlin C, Millar C, Droege F, Kjeldsen A, Suppressa P, Ugolini S, Coote N, Fialla A, Geisthoff U, Lenato G, Mager H, Pagella F, Post M, Sabba C, Sure C, Torring P, Dupuis-Girod S, Buscarini E and VASCERN-HHT. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019;14(1):1179. https://doi.org/10.1186/s13023-019-1179-1
  47. Jauss M, Zanette E. Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler Sonography. Cerebrovascular Diseases. 2000;10(6):490-496.  https://doi.org/10.1159/000016119
  48. Chechetkin AO. Methodological aspects of diagnostics of the open foramen ovale using contrast transcranial Doppler (literature review). Ul’trazvukovaya i funktsional’naya diagnostika. 2007;1:102-118. (In Russ.).
  49. Suslina ZA, Fonyakin AV, Chechetkin AO, Geraskina LA, Glebov MV, Nikitin YuM, Kravchenko MA. Pathogenetic heterogeneity of ischemic stroke and patent foramen ovale Annaly klinicheskoy i eksperimental’noy nevrologii. 2008;2(3):4-8. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.